XML 76 R80.htm IDEA: XBRL DOCUMENT
v2.4.0.8

18. Pro Forma Financials for Acquisition of Canterbury, Hygeia, Paloma and VasculoMedics (Details) (USD $) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2014 | Mar. 31, 2013 | Dec. 31, 2013 | Dec. 31, 2012
Revenues | $ 0 | $ 0 | $ 71,667 | $ 374,542
Cost of revenues | 0 | 0 | 0 | 235,803
Gross margin | 0 | 0 | 71,667 | 138,739
Operating expenses |  |  |  |
General and administrative | 611,845 | 624,674 | 2,008,118 | 4,570,161
Warrants, options and stock compensation | 149,885 | 1,316,148 | 4,228,317 | 3,643,662
Legal and professional services | 131,686 | 143,103 | 1,071,392 | 2,128,898
Depreciation and amortization | 478,104 | 8,687 | 675,757 | 164,043
Total operating expenses | 1,371,520 | 2,092,612 | 12,988,997 | 11,930,608
Loss from operations | (1,371,520) | (2,092,612) | (12,917,330) | (11,791,869)
Other (income)/expenses |  |  |  |
Loss on adjustments to fair value of derivative liability | 0 | 236,850 | (8,980,077) | (6,907,748)
Other income | (49,639) | (2,564) | (71,631) | 379,188
Interest expense | 58,294 | 22,971 | 228,294 | 167,894
Total other expenses | 8,655 | 257,257 | (10,459,381) | (4,942,054)
Net loss from continuing operations | (1,380,175) | (2,349,869) |  |
Net loss from discontinued operations | 0 | (126,911) |  |
Net loss | (1,380,175) | (2,476,780) | (2,457,949) | (6,849,815)
Basic and diluted loss per share | $ (0.23) | $ (2.91) | $ (1.00) | $ (8.16)
Fully-diluted weighted average shares outstanding | 5,934,474 | 1,207,534 | 2,646,603 | 1,121,987
RestorGenex |  |  |  |
Revenues |  |  |  |
Cost of revenues |  |  |  |
Gross margin |  |  |  |
Operating expenses |  |  |  |
General and administrative | 611,845 | 624,674 |  |
Warrants, options and stock compensation | 149,885 | 1,316,148 |  |
Legal and professional services | 131,686 | 143,103 |  |
Depreciation and amortization | 478,104 | 8,687 |  |
Total operating expenses | 1,371,520 | 2,092,612 |  |
Loss from operations | (1,371,520) | (2,092,612) |  |
Other (income)/expenses |  |  |  |
Loss on adjustments to fair value of derivative liability |  | 236,850 |  |
Other income | (49,639) | (2,564) |  |
Interest expense | 58,294 | 22,971 |  |
Total other expenses | 8,655 | 257,257 |  |
Net loss from continuing operations | (1,380,175) | (2,349,869) |  |
Net loss from discontinued operations |  | (126,911) |  |
Net loss | (1,380,175) | (2,476,780) |  |
Basic and diluted loss per share | $ (0.23) | $ (2.77) |  |
Basic weighted average shares outstanding | 5,934,474 | 892,534 |  |
Fully-diluted weighted average shares outstanding |  | 1,207,534 |  |
Paloma |  |  |  |
Revenues |  |  |  |
Cost of revenues |  |  |  |
Gross margin |  |  |  |
Operating expenses |  |  |  |
General and administrative | 102,153 | 47,880 |  |
Legal and professional services | 1,725 | 17,254 |  |
Depreciation and amortization | 634 |  |  |
Total operating expenses | 104,512 | 65,134 |  |
Loss from operations | (104,512) | (65,134) |  |
Other (income)/expenses |  |  |  |
Other income | (25,397) | (63,910) |  |
Interest expense | 29,925 | 20,781 |  |
Total other expenses | 4,528 | (43,129) |  |
Net loss from continuing operations | (109,040) | (22,005) |  |
Net loss from discontinued operations |  |  |  |
Net loss | (109,040) | (22,005) |  |
Basic and diluted loss per share |  |  |  |
Basic weighted average shares outstanding | 2,500,000 | 2,500,000 |  |
Fully-diluted weighted average shares outstanding |  | 2,500,000 |  |
VasculoMedics |  |  |  |
Revenues |  |  |  |
Cost of revenues |  |  |  |
Gross margin |  |  |  |
Operating expenses |  |  |  |
General and administrative |  |  |  |
Warrants, options and stock compensation |  |  |  |
Legal and professional services |  |  |  |
Depreciation and amortization |  |  |  |
Total operating expenses |  |  |  |
Loss from operations |  |  |  |
Other (income)/expenses |  |  |  |
Other income |  |  |  |
Interest expense |  |  |  |
Total other expenses |  |  |  |
Net loss from continuing operations |  |  |  |
Net loss from discontinued operations |  |  |  |
Net loss |  |  |  |
Basic and diluted loss per share |  |  |  |
Basic weighted average shares outstanding | 220,000 | 220,000 |  |
Fully-diluted weighted average shares outstanding |  | 220,000 |  |
Pro Forma Adjustments |  |  |  |
Revenues |  |  |  |
Cost of revenues |  |  |  |
Gross margin |  |  |  |
Operating expenses |  |  |  |
General and administrative | 81,250 | 848,732 |  |
Warrants, options and stock compensation |  |  |  |
Legal and professional services |  |  |  |
Depreciation and amortization | 27,755 | 687,713 |  |
Total operating expenses | 109,005 | 1,536,445 |  |
Loss from operations | (109,005) | (1,536,445) |  |
Other (income)/expenses |  |  |  |
Other income |  |  |  |
Interest expense |  |  |  |
Total other expenses |  |  |  |
Net loss from continuing operations | (109,005) | (1,536,445) |  |
Net loss from discontinued operations |  |  |  |
Net loss | (109,005) | (1,536,445) |  |
Basic and diluted loss per share |  |  |  |
Basic weighted average shares outstanding |  |  |  |
Fully-diluted weighted average shares outstanding |  |  |  |
Pro Forma Combined |  |  |  |
Revenues |  | 46,155 |  |
Cost of revenues |  | 54,765 |  |
Gross margin |  | (8,610) |  |
Operating expenses |  |  |  |
General and administrative | 795,248 | 1,552,617 |  |
Warrants, options and stock compensation | 149,885 | 1,316,148 |  |
Legal and professional services | 133,411 | 185,792 |  |
Depreciation and amortization | 506,493 | 700,612 |  |
Total operating expenses | 1,585,037 | 3,755,169 |  |
Loss from operations | (1,585,037) | (3,763,779) |  |
Other (income)/expenses |  |  |  |
Loss on adjustments to fair value of derivative liability |  | 236,850 |  |
Other income | (75,036) | (66,474) |  |
Interest expense | 88,219 | 46,110 |  |
Total other expenses | 13,183 | (216,486) |  |
Net loss from continuing operations | (1,598,220) | (3,980,265) |  |
Net loss from discontinued operations |  | (126,911) |  |
Net loss | (1,598,220) | (4,107,176) |  |
Basic and diluted loss per share | $ (0.18) | $ (0.86) |  |
Basic weighted average shares outstanding | 8,654,474 | 4,762,650 |  |
Fully-diluted weighted average shares outstanding |  | 5,077,650 |  |
Canterbury |  |  |  |
Revenues |  | 46,155 |  |
Cost of revenues |  | 54,765 |  |
Gross margin |  | (8,610) |  |
Operating expenses |  |  |  |
General and administrative |  | 31,331 |  |
Warrants, options and stock compensation |  |  |  |
Legal and professional services |  | 25,435 |  |
Depreciation and amortization |  | 4,212 |  |
Total operating expenses |  | 60,978 |  |
Loss from operations |  | (69,588) |  |
Other (income)/expenses |  |  |  |
Other income |  |  |  |
Interest expense |  | 2,358 |  |
Total other expenses |  | 2,358 |  |
Net loss from continuing operations |  | (71,946) |  |
Net loss from discontinued operations |  |  |  |
Net loss |  | (71,946) |  |
Basic and diluted loss per share |  |  |  |
Basic weighted average shares outstanding |  | 1,150,116 |  |
Fully-diluted weighted average shares outstanding |  | 1,150,116 |  |
Hygeia |  |  |  |
Revenues |  |  |  |
Cost of revenues |  |  |  |
Gross margin |  |  |  |
Operating expenses |  |  |  |
General and administrative |  |  |  |
Warrants, options and stock compensation |  |  |  |
Legal and professional services |  |  |  |
Depreciation and amortization |  |  |  |
Total operating expenses |  |  |  |
Loss from operations |  |  |  |
Other (income)/expenses |  |  |  |
Other income |  |  |  |
Total other expenses |  |  |  |
Net loss from continuing operations |  |  |  |
Net loss from discontinued operations |  |  |  |
Net loss |  |  |  |
Basic and diluted loss per share |  |  |  |
Basic weighted average shares outstanding |  |  |  |
Fully-diluted weighted average shares outstanding |  |  |  |

X
- Definition Basic weighted average shares outstanding + References No definition available. + Details
Name: | RESX_BasicAndFullydilutedWeightedAverageSharesOutstanding
Namespace Prefix: | RESX_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants, options and stock compensation + References No definition available. + Details
Name: | RESX_WarrantExpenseAndFairValueChargeForStockSales
Namespace Prefix: | RESX_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of gain (loss) from the increase (decrease) in fair value of derivative and nonderivative instruments designated as fair value hedging instruments recognized in the income statement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 25 -Section 50 -Paragraph 1 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986 + Details
Name: | us-gaap_ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 2 -Article 5 + Details
Name: | us-gaap_CostOfRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. + References No definition available. + Details
Name: | us-gaap_EarningsPerShareBasicAndDiluted
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GeneralAndAdministrativeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1,2) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_GrossProfit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4613673-111683 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.13) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_IncomeLossFromContinuingOperations
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of income (loss) from a disposal group, net of income tax, reported as a separate component of income before extraordinary items after deduction or consideration of the amount allocable to noncontrolling interests. Includes, net of tax, income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 + Details
Name: | us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 7 -Article 5 + Details
Name: | us-gaap_NonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_NonoperatingIncomeExpenseAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. + References No definition available. + Details
Name: | us-gaap_OperatingExpenses
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_OperatingExpensesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07.2(a),(b),(c),(d)) -URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 946 -SubTopic 225 -Section 45 -Paragraph 3 -Subparagraph (k) -URI http://asc.fasb.org/extlink&oid=6488370&loc=d3e13550-115849 + Details
Name: | us-gaap_ProfessionalFees
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591552-111686 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 19 -URI http://asc.fasb.org/extlink&oid=7656940&loc=SL4569616-111683 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 1A -Subparagraph (a),(c) -URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=31814832&loc=SL4591551-111686 + Details
Name: | us-gaap_ProfitLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_SalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256 + Details
Name: | us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration